secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jade Biosciences, Inc. (JBIO)
CIK:        0001798749
Form:       8-K
Filed at:   2024-10-31T23:59:59+00:00
Accession:  0001104659-24-112896
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 3.02, 5.01, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aerovate to merge with Jade Biosciences; Jade holders to own 98.4%
------------------------------------------------------------------

- Aerovate (AVTE) reverse-merges with Jade; pre-merger Jade stockholders receive 98.4% of combined firm; Aerovate holders receive 1.6%.
- Concurrent ~$300M PIPE led by existing Jade investors, including conversion of $95M convertible notes.
- Aerovate to pay ~$65M cash dividend to its pre-merger stockholders; combined company renamed Jade Biosciences, expects ticker 'JBIO'.
- Post-closing board will be six members, all designated by Jade; closing requires stockholder and regulatory approvals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1798749/000110465924112896/0001104659-24-112896-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1798749/000110465924112896/tm2427147d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-112896

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer